Related Experiment Videos

Effect of folic acid supplementation on small-for-gestational-age infants born at term

N Foged1, K Lillquist, J Rolschau

  • 1Department of Paediatrics, Odense University Hospital, Denmark.

Insights

Folic acid (FA) supplementation did not significantly impact growth or blood markers in small-for-gestational-age infants. Erythrocyte folate levels were higher in breast-fed infants not receiving supplements.

Area of Science:

  • Neonatal Nutrition
  • Pediatric Hematology
  • Folate Metabolism

Background:

  • Small-for-gestational-age (SGA) infants may have altered nutritional needs.
  • Folate is crucial for cell growth and DNA synthesis.
  • Early life nutrition impacts long-term health outcomes.

Purpose of the Study:

  • To evaluate the effect of folic acid supplementation on SGA infants.
  • To assess the impact of folate on hematological parameters and growth.
  • To investigate folate status in relation to feeding method.

Main Methods:

  • Double-blind, randomized controlled trial.
  • 250 micrograms folic acid (FA) or placebo daily for 3 months.
  • 21 term-born, small-for-gestational-age infants.
  • Measurements included hemoglobin, hematocrit, weight, length, and erythrocyte folate.

Main Results:

  • No significant differences in hemoglobin, hematocrit, weight, or length between FA-supplemented and placebo groups.
  • Negative correlation between gestational age and erythrocyte folate at 1 week.
  • Higher erythrocyte folate in breast-fed infants compared to formula-fed infants without supplementation.

Conclusions:

  • Folic acid supplementation did not alter growth or hematological parameters in SGA infants during the first 3 months.
  • Gestational age influences early erythrocyte folate levels.
  • Breastfeeding may support higher folate status in infants compared to formula feeding.

Related Concept Videos